Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Latest Breaking News

Sgent

(5,857 posts)

9. The evidience is that

Reply to Me. (Reply #6)

Fri Jun 11, 2021, 01:41 AM

Jun 2021

it removes plaques from the brain. Unfortunately, those same patients didn't improve -- and this has been shown in multiple trials for this and other drugs. Our hypothesis that plaques were causing Az is unfortunately wrong (they are a symptom).

In addition, this drug causes brain swelling in 40% of patients, so its not benign.

The FDA isn't supposed to look at cost, but spending 60k / year + another 20-40 in MRI's for monitoring is insane.

Edit history

Please sign in to view edit histories.

12 replies

= new reply since forum marked as read

Highlight:

Three F.D.A. Advisers Resign Over Agency's Approval of Alzheimer's Drug [View all] Yo_Mama_Been_Loggin Jun 2021 OP

Kick dalton99a Jun 2021 #1

Interesting. elleng Jun 2021 #2

It was a tough call. Families are desperate for anything, but is it false hope? JohnSJ Jun 2021 #3

We are sworn to "first do no harm" and giving false hope IS doing harm hlthe2b Jun 2021 #5

If the science does not support the drugs claims then the answer is yes, its false hope. cstanleytech Jun 2021 #8

Somebody is paying somebody I_UndergroundPanther Jun 2021 #4

Short Term Has Been Promising So Far Me. Jun 2021 #6

The evidience is that Sgent Jun 2021 #9

60 Minutes had a segment on 90+ yr olds that Deminpenn Jun 2021 #10

INteresting Me. Jun 2021 #11

Is there some left over Qrump appointees in the decision making process in the FDA? KS Toronado Jun 2021 #7

K&R ck4829 Jun 2021 #12